Glen is deeply engaged in Avita’s mission as an industry advocate and thought leader in HIV patient care and in advancing the continuation of the 340B program that benefits its patients and partners. He represents Avita to pharma and government officials, sharing the organization’s perspective and discussing industry activity. Glen leads efforts to expand Avita’s program scope and continues to explore educational opportunities that improve the health and lives of the patients it serves. As an advocate for Avita’s inclusive culture, he plays a key role in building internal programs and benefits framed around cultural competency.
Glen has a 30-year career overseeing HIV and Hepatitis business and strategy for Walgreens and its parent company, Walgreens Boots Alliance (WBA). Prior to WBA, he owned independent pharmacies in the Chicago area. Glen serves on the board of Prevention Access Campaign, a global HIV advocacy organization best known for creating and leading the Undetectable = Untransmittable (U=U) movement. He also serves on the board of Community Voices for 340B, an advocacy organization that seeks to raise awareness of the important role the 340B program plays in protecting and improving health care access and the quality of care for communities nationwide. Glen served on the board of pharmacy for the State of Illinois and earned certificates from the American Academy of HIV Medicine and Apexus 340B. He received a B.S. in Pharmacy from St. Louis College of Pharmacy in St. Louis, Missouri.
“Since the early days of the HIV epidemic, I have committed myself to providing stigma-free health care in my community and communities around the country. I’m proud to be part of the Avita Care Solutions team as we continue to serve those most in need, while treating our patients and partners with respect and compassion.”